CAPR Capricor Therapeutics, Inc. - Common Stock
$7.70
价格 · 八月 19, 2026
截至...的财报数据 八月 14, 2026
52周区间
$3–$40
13% of range
分析师评级
HOLD
15 analysts
目标价
$10
+36% upside
P/E (TTM)
-3.4
ROE
-51.1%
净利润率
—
CAPR 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$7.70
市值
$442M
P/E (TTM)
-3.4
每股收益 (TTM)
$-2.26
营收 (TTM)
$0
股息收益率
—
ROE
-51.1%
负债/权益
—
52周区间
$3 – $40
CAPR 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2016-12-31
→
2025-12-31
EPS
$-2.26
2016-12-31
→
2025-12-31
自由现金流
$-73M
2016-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CAPR
同行中位数
P/E (TTM)
-3.4
17.4
P/B (市净率)
1.4
4.8
Price / FCF (股价/自由现金流)
-6.1
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CAPR
同行中位数
ROA
-39.9%
-41.1%
ROE
-51.1%
-52.6%
ROIC
-35.4%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CAPR
同行中位数
Current Ratio (流动比率)
9.0
7.7
Quick Ratio (速动比率)
8.0
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CAPR
同行中位数
Revenue YoY (营收同比增长)
-11.6%
—
Revenue CAGR 3Y (营收3年复合年增长率)
349.7%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CAPR
同行中位数
CAPR 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
持有
15 位分析师
- 强烈买入 0 0.0%
- 买入 0 0.0%
- 持有 12 80.0%
- 卖出 1 6.7%
- 强烈卖出 2 13.3%
12个月价格目标
4 位分析师 · 2026-08-16
中位数
$6.00
平均值
$10.50
现在
$7.70
最低
$2.00
最高
$28.00
中位数目标
$6.00
-22.1%
平均目标
$10.50
+36.4%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.06%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.70 | $-0.60 | -0.10% |
| 2026年3月31日 | $-0.59 | $-0.54 | -0.05% |
| 2025年12月31日 | $-0.62 | $-0.55 | -0.07% |
| 2025年9月30日 | $-0.54 | $-0.56 | 0.02% |
| 2025年6月30日 | $-0.57 | $-0.48 | -0.09% |
| 2025年3月31日 | $-0.53 | $-0.32 | -0.21% |
| 2024年12月31日 | $-0.16 | $-0.27 | 0.11% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
| CMPX | $958M | — | — | — | -45.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | — |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22M | $25M | $3M | $244.9K | $310.2K | $1M | $2M | $3M | $4M | $6M | $5M | |
| R&D Expense | $84M | $50M | $36M | $22M | $14M | $8M | $5M | $12M | $11M | $16M | $14M | $8M | |
| SG&A Expense | $24M | $15M | $13M | $10M | $8M | $6M | $4M | $5M | $5M | $5M | $4M | $3M | |
| Operating Expenses | $108M | $65M | $49M | $32M | $21M | $14M | $9M | $17M | $16M | $21M | $18M | $11M | |
| Operating Income | $-108M | $-43M | $-24M | $-30M | $-21M | $-14M | $-8M | $-15M | $-13M | $-17M | $-13M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | $0 | $398.8K | $344.7K | $248.6K | $200.5K | |
| Other Non-op | $3M | $2M | $2M | $677.9K | $915.9K | $32.9K | $92.1K | $136.0K | $15M | $-2M | $-245.5K | $-198.6K | |
| Pretax Income | $-105M | $-40M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.6K | $1.6K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-105M | $-40M | $-22M | $-29M | $-20M | $-14M | $-8M | $-15M | $2M | $-19M | $-13M | $-6M | |
| EPS (Basic) | $-2.26 | $-1.15 | $-0.83 | $-1.18 | $-0.87 | $-0.88 | · | · | $0.10 | $-1.01 | · | · | |
| EPS (Diluted) | $-2.26 | $-1.15 | $-0.83 | $-1.18 | $-0.87 | $-0.88 | · | $-0.52 | $0.09 | $-1.01 | · | · | |
| Shares (Basic) | 46,478,416 | 35,218,628 | 26,778,360 | 24,552,688 | 23,089,323 | 15,571,056 | 3,711,333 | 2,941,084 | 23,193,278 | 18,551,013 | · | · | |
| Shares (Diluted) | 46,478,416 | 35,218,628 | 26,778,360 | 24,552,688 | 23,089,323 | 15,571,056 | 3,711,333 | 2,941,084 | 26,788,076 | 18,551,013 | · | · | |
| EBITDA | $-106M | $-41M | $-23M | $-29M | $-21M | $-14M | $-8M | · | $-13M | $-17M | $-13M | $-6M |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $288M | $11M | $15M | $10M | $35M | $33M | $4M | $4M | $6M | $3M | $6M | $8M | |
| Short-term Investments | · | $140M | $25M | $32M | $0 | · | $6M | $3M | $8M | $13M | $8M | $0 | |
| Prepaid Expense | $5M | $2M | $995.8K | $919.9K | $1M | $1M | $571.4K | $724.2K | $501.2K | $342.9K | $210.6K | $235.5K | |
| Current Assets | $323M | $163M | $51M | $43M | $36M | $34M | $11M | $8M | $16M | $18M | $14M | $12M | |
| PP&E (Net) | $18M | $6M | $6M | $5M | $2M | $850.8K | $442.8K | $574.2K | $372.1K | $435.3K | $318.6K | $229.5K | |
| PP&E (Gross) | $23M | $9M | $8M | $6M | $3M | $2M | $1M | $1M | $713.7K | $686.0K | $492.3K | $341.0K | |
| Accum. Depreciation | $5M | $3M | $2M | $1M | $756.7K | $718.6K | $579.0K | $456.0K | $341.6K | $250.7K | $173.7K | $111.6K | |
| Intangibles | · | · | · | · | $0 | $2.2K | $6.5K | $49.8K | $93.0K | $142.3K | $191.0K | $239.8K | |
| Total Assets | $356M | $170M | $59M | $50M | $41M | $35M | $11M | $9M | $16M | $19M | $16M | $14M | |
| Accounts Payable | $2M | $3M | $6M | $5M | $3M | $3M | $898.0K | $1M | $1M | $3M | $3M | $2M | |
| Accrued Liabilities | $16M | $5M | · | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | · | · | · | · | $0 | $246.7K | $0 | · | · | · | · | · | |
| Current Liabilities | $36M | $21M | $31M | $24M | $4M | $3M | $898.0K | $1M | $2M | $5M | $7M | $6M | |
| Capital Leases | $14M | $616.3K | $1M | $2M | $2M | $0 | · | · | · | · | · | · | |
| Total Liabilities | $50M | $25M | $36M | $38M | $10M | $6M | $4M | $5M | $5M | $23M | $17M | $20M | |
| Total Debt | · | · | · | · | $0 | $246.7K | · | · | · | · | · | · | |
| Common Stock | $57.4K | $45.6K | $31.1K | $25.2K | $24.2K | $20.6K | $5.2K | $3.1K | $26.3K | $21.4K | $16.3K | $11.7K | |
| Retained Earnings | $-305M | $-200M | $-159M | $-137M | $-108M | $-88M | $-74M | $-67M | $-52M | $-54M | $-35M | $-22M | |
| AOCI | $283.2K | $1M | $235.8K | $105.2K | $0 | $0 | $-757 | $12.4K | $11.6K | $3.5K | $9.4K | $0 | |
| Stockholders' Equity | $306M | $145M | $23M | $12M | $31M | $28M | $7M | $5M | $11M | $-4M | $-1M | $-6M | |
| Liabilities + Equity | $356M | $170M | $59M | $50M | $41M | $35M | $11M | $9M | $16M | $19M | $16M | $14M | |
| Shares Outstanding | 57,370,909 | 45,582,288 | 31,148,320 | 25,241,402 | 24,185,001 | 20,577,123 | 5,227,398 | 3,138,748 | 26,270,491 | 21,399,019 | 16,254,985 | 11,707,051 |
现金流 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $1M | $533.1K | $245.7K | $143.9K | $172.0K | $157.7K | $144.2K | $125.7K | $110.9K | $41.9K | |
| Stock-based Comp | · | $10M | $7M | $4M | $3M | $2M | $701.0K | $2M | $2M | $2M | $2M | $496.9K | |
| Amort. of Intangibles | · | · | · | $0 | $2.2K | $4.3K | $43.3K | $43.3K | $49.2K | $48.7K | $48.7K | $10.7K | |
| Other Non-cash | $33M | $-11M | $-12M | $29M | $1.8K | $2M | $-52.6K | · | $-19M | $917.0K | $356.0K | $7M | |
| Operating Cash Flow | $-70M | $-40M | $-26M | $5M | $-17M | $-10M | $-7M | $-14M | $-14M | $-14M | $-11M | $958.6K | |
| CapEx | $3M | $1M | $1M | $2M | $1M | $547.6K | $0 | $316.5K | $32.2K | $192.0K | $129.7K | $162.7K | |
| Investing Cash Flow | $97M | $-116M | $5M | $-35M | $-1M | $5M | $-3M | $5M | $5M | $-5M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $500.0K | $5M | $0 | $5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $500.0K | $5M | $0 | $5M | |
| Stock Issued | $237M | $152M | $26M | $5M | $20M | $27M | $9M | $7M | $11M | $14M | $16M | $0 | |
| Stock Repurchased | · | · | · | · | · | $0 | $193 | $0 | · | · | · | · | |
| Net Stock Activity | $237M | $152M | $26M | $5M | $20M | $27M | $9M | · | $11M | $14M | $16M | · | |
| Financing Cash Flow | $249M | $153M | $26M | $5M | $20M | $33M | $9M | $7M | $12M | $19M | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | $-2M | $-2M | $6M | |
| Taxes Paid | $1.6K | $1.6K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-73M | $-41M | $-27M | $3M | $-18M | $-11M | $-7M | · | $-14M | $-16M | $-11M | $772.1K |
盈利能力 6
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -191.1% | -95.6% | -1163.9% | -8549.9% | -4412.6% | -769.5% | · | -482.4% | -424.6% | -228.6% | -125.7% | |
| Net Margin | · | -181.7% | -88.5% | -1137.4% | -8175.9% | -4401.9% | -760.4% | · | 91.2% | -470.3% | -233.0% | -129.9% | |
| EBITDA Margin | · | -184.7% | -91.4% | -1143.0% | -8449.5% | -4366.2% | -752.4% | · | -477.0% | -421.4% | -226.6% | -124.8% | |
| ROA | -39.9% | -35.3% | -41.0% | -63.5% | -52.7% | -59.7% | -75.1% | · | 13.9% | -108.0% | -86.6% | -64.9% | |
| ROE | -51.1% | -37.9% | -214.2% | -213.3% | -58.8% | -46.6% | -146.8% | · | 67.3% | 747.1% | 353.2% | 183.3% | |
| ROIC | -35.4% | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 7.8 | 1.6 | 1.8 | 8.8 | 11.3 | 11.7 | · | 9.4 | 3.7 | 2.1 | 1.8 | |
| Quick Ratio | 8.0 | 7.2 | 1.3 | 1.8 | 8.4 | 11.0 | 11.0 | · | 8.5 | 3.3 | 2.1 | 1.3 | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -32.3 | -49.3 | -50.7 | -30.0 |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | 0.5 | 0.1 | 0.0 | 0.0 | 0.1 | · | 0.2 | 0.2 | 0.4 | 0.5 |
增长率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -11.6% | 886.8% | 941.9% | -21.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | 349.7% | 332.9% | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $22M | $25M | $3M | $244.9K | $310.2K | $1M | $2M | $3M | $4M | $6M | $5M | |
| Net Income TTM | $-105M | $-40M | $-22M | $-29M | $-20M | $-14M | $-8M | $-15M | $2M | $-19M | $-13M | $-6M | |
| Market Cap | $1.66B | $629M | $152M | $97M | $71M | $71M | $7M | · | $415M | $569M | $499M | $439M | |
| Enterprise Value | · | · | · | · | $36M | $38M | · | · | · | · | · | · | |
| P/E | -12.8 | -12.0 | -5.9 | -3.3 | -3.4 | -3.9 | · | -7.9 | 175.6 | -26.3 | · | · | |
| P/S | · | 28.2 | 6.0 | 38.2 | 289.4 | 227.5 | 6.7 | · | 155.7 | 142.4 | 90.4 | 91.7 | |
| P/B | 5.4 | 4.3 | 6.7 | 8.3 | 2.3 | 2.5 | 1.0 | · | 37.0 | -142.2 | -483.7 | -70.3 | |
| P / Tangible Book | 5.4 | 4.3 | 6.7 | 8.3 | 2.3 | 2.5 | · | · | · | · | · | · | |
| P / Cash Flow | -23.7 | -15.7 | -6.0 | 19.8 | -4.2 | -7.0 | -1.0 | · | -29.2 | -36.0 | -46.1 | 458.0 | |
| P / FCF | -22.8 | -15.3 | -5.7 | 33.4 | -3.9 | -6.7 | -1.0 | · | -29.1 | -35.6 | -45.6 | 568.6 | |
| EV / EBITDA | · | · | · | · | -1.7 | -2.8 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | -2.0 | -3.6 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | 146.9 | 123.0 | · | · | · | · | · | · | |
| Earnings Yield | -7.8% | -8.3% | -17.0% | -30.6% | -29.7% | -25.7% | · | -12.7% | 0.57% | -3.8% | · | · |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $11M | $2M | $4M | $5M | $12M | $6M | $4M | $3M | $959.9K | $2M | |
| R&D Expense | $29M | $27M | $23M | $20M | $22M | $19M | $15M | $12M | $13M | $11M | $10M | $10M | $9M | $8M | $6M | $6M | |
| SG&A Expense | $14M | $9M | $6M | $6M | $6M | $6M | $4M | $3M | $3M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | |
| Operating Expenses | $43M | $37M | $29M | $26M | $28M | $25M | $19M | $15M | $16M | $15M | $13M | $13M | $12M | $11M | $9M | $8M | |
| Operating Income | $-43M | $-37M | $-29M | $-26M | $-28M | $-25M | $-8M | $-13M | $-12M | $-10M | $-1M | $-7M | $-8M | $-8M | $-8M | $-6M | |
| Other Non-op | $2M | $3M | $-1M | $2M | $2M | $591.4K | $581.2K | $453.2K | $591.4K | $471.8K | $519.2K | $474.0K | $380.7K | $416.4K | $345.4K | $106.6K | |
| Pretax Income | $-41M | $-34M | · | · | $-26M | $-24M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.6K | $0 | · | · | $1.6K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-41M | $-34M | $-30M | $-25M | $-26M | $-24M | $-7M | $-13M | $-11M | $-10M | $-762.1K | $-6M | $-7M | $-8M | $-8M | $-6M | |
| EPS (Basic) | $-0.70 | $-0.59 | $-0.62 | $-0.54 | $-0.57 | $-0.53 | $-0.11 | $-0.38 | $-0.35 | $-0.31 | $0.02 | $-0.25 | $-0.29 | $-0.31 | $-0.31 | $-0.26 | |
| EPS (Diluted) | $-0.70 | $-0.59 | $-0.62 | $-0.54 | $-0.57 | $-0.53 | $-0.11 | $-0.38 | $-0.35 | $-0.31 | $0.02 | $-0.25 | $-0.29 | $-0.31 | $-0.31 | $-0.26 | |
| Shares (Basic) | 57,926,347 | 57,434,267 | -90,583,439 | 45,716,151 | 45,709,071 | 45,636,633 | -61,068,028 | 33,090,063 | 31,841,964 | 31,354,629 | -49,622,012 | 25,817,676 | 25,335,342 | 25,247,354 | -48,485,998 | 24,431,787 | |
| Shares (Diluted) | 57,926,347 | 57,434,267 | -90,583,439 | 45,716,151 | 45,709,071 | 45,636,633 | -61,068,028 | 33,090,063 | 31,841,964 | 31,354,629 | -49,622,012 | 25,817,676 | 25,335,342 | 25,247,354 | -48,485,998 | 24,431,787 | |
| EBITDA | $-43M | $-36M | · | $-26M | $-28M | $-25M | · | $-13M | $-12M | $-10M | · | $-7M | $-8M | $-8M | · | $-6M |
资产负债表 19
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $105M | $288M | $20M | $23M | $29M | $11M | $68M | $11M | $6M | $15M | $9M | $10M | $11M | $10M | $8M | |
| Short-term Investments | · | · | · | $79M | $100M | $116M | · | $17M | $19M | $34M | $25M | $20M | $28M | $35M | $32M | $38M | |
| Prepaid Expense | $4M | $4M | $5M | $2M | $1M | $1M | $2M | $385.1K | $837.2K | $1M | $995.8K | $458.4K | $583.8K | $875.1K | $919.9K | $343.7K | |
| Current Assets | $242M | $283M | $323M | $101M | $124M | $146M | $163M | $86M | $31M | $41M | $51M | $30M | $39M | $47M | $43M | $48M | |
| PP&E (Net) | $36M | $29M | $18M | $11M | $8M | $6M | $6M | $5M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $4M | |
| PP&E (Gross) | $42M | $34M | $23M | $16M | $12M | $10M | $9M | $9M | $8M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | |
| Accum. Depreciation | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Total Assets | $369M | $326M | $356M | $126M | $134M | $154M | $170M | $93M | $38M | $49M | $59M | $37M | $46M | $54M | $50M | $54M | |
| Accounts Payable | $3M | $4M | $2M | $3M | $5M | $5M | $3M | $7M | $6M | $6M | $6M | $7M | $5M | $5M | $5M | $4M | |
| Accrued Liabilities | $16M | $11M | $16M | $10M | $7M | $4M | $5M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $33M | $34M | $36M | $28M | $28M | $22M | $21M | $20M | $22M | $26M | $31M | $33M | $35M | $37M | $24M | $23M | |
| Capital Leases | $90M | $14M | $14M | $14M | $194.6K | $407.4K | $616.3K | $834.9K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $123M | $48M | $50M | $43M | $29M | $26M | $25M | $25M | $27M | $31M | $36M | $39M | $43M | $48M | $38M | $39M | |
| Common Stock | $58.1K | $57.7K | $57.4K | $45.7K | $45.7K | $45.7K | $45.6K | $40.3K | $32.0K | $31.6K | $31.1K | $25.9K | $25.8K | $25.3K | $25.2K | $24.7K | |
| Retained Earnings | $-380M | $-339M | $-305M | $-275M | $-250M | $-224M | $-200M | $-193M | $-180M | $-169M | $-159M | $-159M | $-152M | $-145M | $-137M | $-129M | |
| AOCI | $-163.5K | $-253.7K | $283.2K | $844.1K | $1M | $2M | $1M | $96.2K | $155.0K | $307.7K | $235.8K | $113.2K | $179.7K | $95.0K | $105.2K | $122.5K | |
| Stockholders' Equity | $246M | $279M | $306M | $84M | $105M | $128M | $145M | $68M | $12M | $18M | $23M | $-2M | $3M | $6M | $12M | $15M | |
| Liabilities + Equity | $369M | $326M | $356M | $126M | $134M | $154M | $170M | $93M | $38M | $49M | $59M | $37M | $46M | $54M | $50M | $54M | |
| Shares Outstanding | 58,108,989 | 57,664,673 | 57,370,909 | 45,716,975 | 45,711,975 | 45,676,887 | 45,582,288 | 40,332,392 | 31,983,927 | 31,600,183 | 31,148,320 | 25,855,070 | 25,764,312 | 25,255,154 | 25,241,402 | 24,702,684 |
现金流 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $561.8K | $534.7K | $502.6K | $494.7K | $486.3K | $405.4K | $375.7K | $361.2K | $356.9K | $331.4K | $307.6K | $276.5K | $254.7K | $230.1K | $191.6K | $137.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Other Non-cash | · | $4M | · | · | · | $18M | · | · | · | $5M | · | · | · | $10M | · | · | |
| Operating Cash Flow | $-31M | $-29M | $-24M | $-20M | $-20M | $-6M | $-15M | $-12M | $-12M | $-1M | $-12M | $-9M | $-9M | $4M | $-7M | $-6M | |
| CapEx | $4M | $5M | $2M | $55.8K | $287.7K | $896.0K | $488.8K | $9.1K | $60.3K | $608.6K | $558.6K | $269.5K | $135.9K | $347.7K | $694.0K | $557.6K | |
| Investing Cash Flow | $-49M | $-155M | $43M | $16M | $15M | $24M | $-123M | $2M | $15M | $-10M | $-6M | $8M | $6M | $-3M | $5M | $-4M | |
| Stock Issued | · | · | · | · | · | · | $81M | $67M | $2M | $2M | $23M | $221.1K | $2M | $0 | $3M | $2M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $1M | $249M | $7.0K | $19.6K | $50.4K | $81M | $67M | $2M | $2M | $23M | $221.1K | $2M | $3.9K | $3M | $2M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | |
| Free Cash Flow | · | $-34M | · | · | · | $-7M | · | · | · | $-2M | · | · | · | $4M | · | · |
盈利能力 6
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -575.2% | -291.9% | -209.2% | · | -111.0% | -197.8% | -274.0% | · | -407.0% | |
| Net Margin | · | · | · | · | · | · | · | -555.2% | -277.0% | -199.6% | · | -103.3% | -188.0% | -260.1% | · | -400.3% | |
| EBITDA Margin | · | · | · | · | · | · | · | -575.2% | -291.9% | -202.5% | · | -111.0% | -197.8% | -266.3% | · | -407.0% | |
| ROA | -16.2% | -14.1% | · | -22.4% | -30.2% | -24.0% | · | -19.3% | -26.1% | -19.0% | · | -14.0% | -14.2% | -13.1% | · | -13.1% | |
| ROE | -23.2% | -16.7% | · | -32.3% | -44.5% | -33.4% | · | -37.8% | -154.6% | -79.5% | · | -93.7% | -68.7% | -50.4% | · | -24.4% | |
| ROIC | -17.4% | -13.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | 8.4 | · | 3.6 | 4.4 | 6.5 | · | 4.2 | 1.4 | 1.6 | · | 0.9 | 1.1 | 1.3 | · | 2.0 | |
| Quick Ratio | 0.6 | 3.1 | · | 3.5 | 4.3 | 6.5 | · | 4.2 | 1.3 | 1.5 | · | 0.9 | 1.1 | 1.2 | · | 2.0 |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17M | $17M | · | $17M | $17M | $17M | · | $17M | $19M | $18M | · | $15M | · | · | · | · | |
| Net Income TTM | $-125M | $-109M | · | $-87M | $-74M | $-58M | · | $-40M | $-35M | $-31M | · | $-28M | $-29M | $-29M | · | $-25M | |
| Market Cap | $1.40B | $1.75B | · | $330M | $454M | $433M | · | $613M | $153M | $215M | · | $88M | $123M | $107M | · | $148M | |
| P/E | -10.0 | -13.6 | · | -3.6 | -5.4 | -6.0 | · | -11.8 | -4.0 | -5.9 | · | -3.1 | -4.2 | -3.6 | · | -5.8 | |
| P/S | 80.8 | 101.2 | · | 19.0 | 26.2 | 25.0 | · | 35.4 | 8.0 | 11.9 | · | 6.0 | · | · | · | · | |
| P/B | 5.7 | 6.3 | · | 3.9 | 4.3 | 3.4 | · | 9.0 | 13.3 | 11.6 | · | -49.5 | 45.1 | 17.2 | · | 9.6 | |
| P / Tangible Book | 5.7 | 6.3 | · | 3.9 | 4.3 | 3.4 | · | 9.0 | 13.3 | 11.6 | · | · | 45.1 | 17.2 | · | 9.6 | |
| P / Cash Flow | · | -59.9 | · | · | · | -67.4 | · | · | · | -169.2 | · | · | · | 25.3 | · | · | |
| P / FCF | · | -51.0 | · | · | · | -59.1 | · | · | · | -114.3 | · | · | · | 27.6 | · | · | |
| Earnings Yield | -10.0% | -7.3% | · | -28.0% | -18.4% | -16.5% | · | -8.5% | -25.2% | -17.1% | · | -32.5% | -24.1% | -28.0% | · | -17.3% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $0 | $22M | $25M | $3M | $244.9K |
| 营业利润率 % | — | -191.1% | -95.6% | -1163.9% | -8549.9% |
| 净收入 | $-105M | $-40M | $-22M | $-29M | $-20M |
| 稀释后每股收益 (EPS) | $-2.26 | $-1.15 | $-0.83 | $-1.18 | $-0.87 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | — | — | — | — | 0.0 |
| 流动比率 | 9.0 | 7.8 | 1.6 | 1.8 | 8.8 |
| 速动比率 | 8.0 | 7.2 | 1.3 | 1.8 | 8.4 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-73M | $-41M | $-27M | $3M | $-18M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 208 家申报者 · $984.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 41 (-35 与上一季度对比) | 31 (+10 与上一季度对比) | 71 (+10 与上一季度对比) | 52 (+10 与上一季度对比) | +5.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $98725592 | 4099900 | 10.03% | 股份 |
| MONTANOVA CAPITAL, LLC | $98554239 | 4092784 | 10.01% | 股份 |
| STATE STREET CORP | $81803372 | 3397150 | 8.31% | 股份 |
| VANGUARD GROUP INC | $64543514 | 2236435 | 6.56% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $55327990 | 2297674 | 5.62% | 股份 |
| GOLDMAN SACHS GROUP INC | $36815454 | 1528881 | 3.74% | 股份 |
| RA CAPITAL MANAGEMENT, L.P. | $36308884 | 1507844 | 3.69% | 股份 |
| Boxer Capital Management, LLC | $33595356 | 1395156 | 3.41% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $28392757 | 1178893 | 2.88% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $25637976 | 1064700 | 2.60% | 买入期权 |
| PERCEPTIVE ADVISORS LLC | $24080000 | 1000000 | 2.45% | 买入期权 |
| FMR LLC | $22104019 | 917941 | 2.25% | 股份 |
| Soleus Capital Management, L.P. | $18342627 | 761737 | 1.86% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $15316975 | 636087 | 1.56% | 股份 |
| DG Capital Management, LLC | $14727208 | 611595 | 1.50% | 股份 |
| Ikarian Capital, LLC | $14549497 | 604215 | 1.48% | 股份 |
| CITADEL ADVISORS LLC | $14078589 | 584659 | 1.43% | 股份 |
| DIADEMA PARTNERS LP | $12868352 | 534400 | 1.31% | 卖出期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $12714240 | 528000 | 1.29% | 卖出期权 |
| PERCEPTIVE ADVISORS LLC | $12040000 | 500000 | 1.22% | 卖出期权 |
| Balyasny Asset Management L.P. | $11723011 | 486836 | 1.19% | 股份 |
| SB Capital Management Inc | $11544028 | 400001 | 1.17% | 股份 |
| CITADEL ADVISORS LLC | $11394656 | 473200 | 1.16% | 买入期权 |
| Caption Management, LLC | $10802288 | 448600 | 1.10% | 买入期权 |
| J. Goldman & Co LP | $10289890 | 427321 | 1.05% | 股份 |
| Jones Hill Capital LP | $10131684 | 420751 | 1.03% | 股份 |
| MERCER GLOBAL ADVISORS INC /ADV | $9697762 | 402731 | 0.99% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $8970739 | 372539 | 0.91% | 股份 |
| Ikarian Capital, LLC | $8428000 | 350000 | 0.86% | 买入期权 |
| DIADEMA PARTNERS LP | $7929544 | 329300 | 0.81% | 买入期权 |
| D. E. Shaw & Co., Inc. | $7585200 | 315000 | 0.77% | 买入期权 |
| GROUP ONE TRADING LLC | $6564425 | 272609 | 0.67% | 股份 |
| CITADEL ADVISORS LLC | $6222272 | 258400 | 0.63% | 卖出期权 |
| RTW INVESTMENTS, LP | $6020000 | 250000 | 0.61% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $5632938 | 233926 | 0.57% | 股份 |
| Palo Alto Investors LP | $5532693 | 229763 | 0.56% | 股份 |
| BANK OF AMERICA CORP /DE/ | $5132387 | 213139 | 0.52% | 股份 |
| Trexquant Investment LP | $4762855 | 197793 | 0.48% | 股份 |
| Caption Management, LLC | $4659480 | 193500 | 0.47% | 卖出期权 |
| BOOTHBAY FUND MANAGEMENT, LLC | $4646525 | 192962 | 0.47% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $4490920 | 186500 | 0.46% | 股份 |
| Moody Aldrich Partners LLC | $4280316 | 177754 | 0.43% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3875387 | 160938 | 0.39% | 股份 |
| Woodline Partners LP | $3341654 | 138773 | 0.34% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $3010000 | 125000 | 0.31% | 买入期权 |
| PFM Health Sciences, LP | $2943082 | 122221 | 0.30% | 股份 |
| LMR Partners LLP | $2819768 | 117100 | 0.29% | 买入期权 |
| Pier Capital, LLC | $2694745 | 111908 | 0.27% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $2550072 | 105900 | 0.26% | 买入期权 |
| Jefferies Financial Group Inc. | $2546580 | 105755 | 0.26% | 股份 |
| JANE STREET GROUP, LLC | $2330944 | 96800 | 0.24% | 买入期权 |
| Point72 Asset Management, L.P. | $2280930 | 94723 | 0.23% | 股份 |
| Swiss National Bank | $2237032 | 92900 | 0.23% | 股份 |
| ADAR1 Capital Management, LLC | $2181479 | 90593 | 0.22% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1967366 | 64716 | 0.20% | 股份 |
| MARSHALL WACE, LLP | $1906895 | 79190 | 0.19% | 股份 |
| Black Diamond Financial, LLC | $1904174 | 79077 | 0.19% | 股份 |
| CITIGROUP INC | $1868656 | 77602 | 0.19% | 股份 |
| OPPENHEIMER & CO INC | $1823193 | 75714 | 0.19% | 股份 |
| Rock Springs Capital Management LP | $1792708 | 74448 | 0.18% | 股份 |
| Longaeva Partners L.P. | $1783028 | 74046 | 0.18% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $1741920 | 57300 | 0.18% | 股份 |
| Caption Management, LLC | $1733760 | 72000 | 0.18% | 股份 |
| RHUMBLINE ADVISERS | $1634564 | 67881 | 0.17% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1610663 | 66888 | 0.16% | 股份 |
| Rafferty Asset Management, LLC | $1453782 | 60373 | 0.15% | 股份 |
| Foundations Investment Advisors, LLC | $1445041 | 60010 | 0.15% | 股份 |
| BARCLAYS PLC | $1401143 | 58187 | 0.14% | 股份 |
| BlackRock, Inc. | $1334104 | 55403 | 0.14% | 股份 |
| Bank of New York Mellon Corp | $1314142 | 54574 | 0.13% | 股份 |
| Quinn Opportunity Partners LLC | $1076328 | 44698 | 0.11% | 股份 |
| JANE STREET GROUP, LLC | $1052296 | 43700 | 0.11% | 卖出期权 |
| MILLENNIUM MANAGEMENT LLC | $1042664 | 43300 | 0.11% | 卖出期权 |
| FRANKLIN RESOURCES INC | $1024941 | 42564 | 0.10% | 股份 |
| GLENMEDE TRUST CO NA | $961634 | 39935 | 0.10% | 股份 |
| D. E. Shaw & Co., Inc. | $884892 | 36748 | 0.09% | 股份 |
| HBK Sorce Advisory LLC | $876689 | 223076 | 0.09% | 股份 |
| AlphaQuest LLC | $867416 | 30056 | 0.09% | 股份 |
| J. Goldman & Co LP | $866880 | 36000 | 0.09% | 买入期权 |
| WOLVERINE TRADING, LLC | $786942 | 106200 | 0.08% | 卖出期权 |
| VANGUARD ASSET MANAGEMENT, Ltd | $776941 | 32265 | 0.08% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $759917 | 31558 | 0.08% | 股份 |
| CITIGROUP INC | $758520 | 31500 | 0.08% | 买入期权 |
| MetLife Investment Management, LLC | $755630 | 31380 | 0.08% | 股份 |
| ALGERT GLOBAL LLC | $737089 | 30610 | 0.07% | 股份 |
| PROFUND ADVISORS LLC | $734007 | 30482 | 0.07% | 股份 |
| HAP Trading, LLC | $731500 | 191200 | 0.07% | 买入期权 |
| ENVESTNET ASSET MANAGEMENT INC | $699717 | 29058 | 0.07% | 股份 |
| Persistent Asset Partners Ltd | $697076 | 831 | 0.07% | 买入期权 |
| Vanguard Global Advisers, LLC | $687532 | 28552 | 0.07% | 股份 |
| JANUS HENDERSON GROUP PLC | $686588 | 22600 | 0.07% | 股份 |
| TWINBEECH CAPITAL LP | $682355 | 28337 | 0.07% | 股份 |
| LPL Financial LLC | $659238 | 27377 | 0.07% | 股份 |
| WOLVERINE TRADING, LLC | $655785 | 88500 | 0.07% | 买入期权 |
| COMMONWEALTH EQUITY SERVICES, LLC | $644740 | 26775 | 0.07% | 股份 |
| Aquatic Capital Management LLC | $632269 | 26257 | 0.06% | 股份 |
| PEAK6 LLC | $602000 | 25000 | 0.06% | 买入期权 |
| SEVEN GRAND MANAGERS, LLC | $602000 | 25000 | 0.06% | 股份 |
| Anson Funds Management LP | $602000 | 25000 | 0.06% | 股份 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $596365 | 24766 | 0.06% | 股份 |
公司内部人士 29 位内幕人士 · 12 位高管 · 15 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Linda Marban | CHIEF EXECUTIVE OFFICER | 2021年1月4日 A | 46715 | 0 | 0 | $0 |
| Peter M Strumph | Chief Executive Officer | 2008年12月11日 P | 4580 | 0 | 0 | $0 |
| Anthony Bergmann | CHIEF FINANCIAL OFFICER | 2026年6月25日 M | 11223 | 0 | 3 | $-759158 |
| Leland Gershell | CHIEF FINANCIAL OFFICER | 2016年3月16日 P | 2100 | 0 | 0 | $0 |
| Daron Evans | Chief Financial Officer | 2012年3月30日 P | 25652 | 0 | 0 | $0 |
| Karen Krasney | EVP, GENERAL COUNSEL | 2026年6月25日 M | 30547 | 0 | 3 | $-759158 |
| Michael T Maurer | CHIEF COMMERCIAL OFFICER | 2026年5月26日 A | — | 0 | 0 | $0 |
| Deborah Ascheim | Chief Medical Officer | 2018年7月24日 A | — | 0 | 0 | $0 |
| Rachel Smith | Vice President of R&D | 2017年12月22日 M | 18504 | 0 | 0 | $0 |
| Andrew Warwick Hamer | VP of Medical Affairs | 2015年3月3日 A | — | 0 | 0 | $0 |
| Hsiao Lieu | Executive VP, Clinical Dev. | 2012年3月30日 P | 12600 | 0 | 0 | $0 |
| Richard B Brewer | Executive Chairman | 2012年3月30日 P | 125000 | 0 | 0 | $0 |
| George W Dunbar JR | 董事 | 2026年1月5日 A | 14306 | 0 | 0 | $0 |
| Karimah Es Sabar | 董事 | 2021年7月23日 A | — | 0 | 0 | $0 |
| Louis Manzo | 董事 | 2021年1月4日 A | 44603 | 0 | 0 | $0 |
| Earl M Collier JR | 董事 | 2021年1月4日 A | — | 0 | 0 | $0 |
| Joshua A Kazam | 董事 | 2018年1月2日 A | 38084 | 0 | 0 | $0 |
| Louis J Grasmick | 董事 | 2016年3月16日 P | 1059740 | 0 | 0 | $0 |
| Gregory W Schafer | 董事 | 2015年3月3日 A | — | 0 | 0 | $0 |
| Peter M Kash | 董事 | 2011年7月18日 J | 1596208 | 0 | 0 | $0 |
| Mieyal Paul A | 董事 | 2011年5月10日 A | — | 0 | 0 | $0 |
| Arie Belldegrun | 董事 | 2011年5月10日 A | — | 0 | 0 | $0 |
| Pedro P Granadillo | 董事 | 2011年5月10日 A | — | 0 | 0 | $0 |
| David M Tanen | 董事 | 2009年7月21日 A | 1511705 | 0 | 0 | $0 |
| Nippon Shinyaku Co Ltd | 10% 所有者 | 2024年9月20日 P | 7090351 | 0 | 0 | $0 |
| CEDARS SINAI MEDICAL CENTER | 10% 所有者 | 2017年5月9日 P | 4049959 | 0 | 0 | $0 |
| Eduardo Marban | 10% 所有者 | 2015年8月19日 P | 268557 | 0 | 0 | $0 |
| Frank Litvack | — | 2026年5月13日 M | 133776 | 0 | 0 | $0 |
| David B Musket | — | 2026年1月5日 A | 22891 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 12 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| NANCELOU, INC., LOUIS GRASMICK, NANCY GRASMICK, GRANT GRASMICK ×4 申报 | 2016年3月21日 | — | 初始申报 | 被动投资 | SEC |
| Linda Marbán, Ph.D. ×2 申报 | 2016年3月21日 | — | 初始申报 | 被动投资 | SEC |
| CONISTON CORPORATION, LOUIS MANZO ×4 申报 | 2016年3月21日 | — | 初始申报 | 被动投资 | SEC |
| Frank Litvack ×2 申报 | 2015年3月13日 | — | 初始申报 | 被动投资 | SEC |
| MD BTI, LLC, Edward St. John, LLC, Edward A. St. John | 2014年3月19日 | — | 初始申报 | 被动投资 | SEC |
| Iota Investors LLC, Wexford Spectrum Investors LLC, Wexford Capital LP, Wexford GP LLC, Charles E. Davidson, Joseph M. Jacobs ×3 申报 | 2013年12月5日 | — | 初始申报 | — | SEC |
| Eduardo Marbán, M.D., Ph.D. | 2013年12月3日 | — | 初始申报 | 被动投资 | SEC |
| Joshua A. Kazam | 2007年9月25日 | — | 初始申报 | 并购/出售 | SEC |
| David M. Tanen | 2007年9月25日 | — | 初始申报 | 并购/出售 | SEC |
| Peter M. Kash | 2007年9月25日 | — | 初始申报 | 并购/出售 | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2007年9月24日 | — | 初始申报 | 董事会活动 | SEC |
| 未披露的报告人 | 2006年8月22日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 24 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.95% | 10606 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.43% | 67108 NS | 2026年4月30日 | N-PORT |
| RSSL · Global X Funds | 0.04% | 18911 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.03% | 2051 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.03% | 10262 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 22465 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.02% | 1604 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.01% | 1622 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 41 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 1350 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 15068 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| IBRN · iShares Trust | — | — | 2026年8月6日 | 每日 |
| WSML · iShares Trust | — | — | 2026年8月5日 | 每日 |